세포 치료 기술 시장(2024-2034년)

The global Cell Therapy Technologies market is projected to grow at a CAGR of 10.7% by 2034

The Cell Therapy Technologies Market Report 2024-2034: This report will prove invaluable to leading firms striving for new revenue pockets if they wish to better understand the industry and its underlying dynamics. It will be useful for companies that would like to expand into different industries or to expand their existing operations in a new region.

Integration of Automation and Robotics into Manufacturing Processes Driving Industry Growth

The integration of automation & robotics within manufacturing sector is propelling the adoption of cell therapy technology. This fusion enhances efficiency, scalability, and reproducibility, while simultaneously mitigating contamination risks. The heightened utilization of closed system bioprocessing technologies further tackles manufacturing challenges by bolstering sterility and safety, all with minimal human intervention.

Nevertheless, obstacles such as steep development costs, intricate manufacturing processes, regulatory complexities, and restricted reimbursement policies pose potential hindrances to industry expansion. To surmount these barriers, there's an escalating demand for cutting-edge analytical tools geared toward quality control and process optimization.

The integration of innovative assays, imaging techniques, and data analytics facilitates real-time monitoring and characterization of cellular products, thereby ensuring heightened efficacy and safety. Additionally, the focus on pioneering biomaterials and scaffolds enhances cell delivery and engraftment, thereby augmenting the allure of cell therapy technologies. Regulatory advancements & collaborations between industry stakeholders & research bodies are fostering innovation and accelerating the transition of cell therapy technologies from laboratory settings to clinical application.

What Questions Should You Ask before Buying a Market Research Report?

How is the cell therapy technologies market evolving?

What is driving and restraining the cell therapy technologies market?

How will each cell therapy technologies submarket segment grow over the forecast period and how much revenue will these submarkets account for in 2034?

How will the market shares for each cell therapy technologies submarket develop from 2024 to 2034?

What will be the main driver for the overall market from 2024 to 2034?

Will leading cell therapy technologies markets broadly follow the macroeconomic dynamics, or will individual national markets outperform others?

How will the market shares of the national markets change by 2034 and which geographical region will lead the market in 2034?

Who are the leading players and what are their prospects over the forecast period?

What are the cell therapy technologies projects for these leading companies?

How will the industry evolve during the period between 2024 and 2034? What are the implications of

cell therapy technologies projects taking place now and over the next 10 years?

Is there a greater need for product commercialisation to further scale the cell therapy technologies market?

Where is the cell therapy technologies market heading and how can you ensure you are at the forefront of the market?

What are the best investment options for new product and service lines?

What are the key prospects for moving companies into a new growth path and C-suite?

You need to discover how this will impact the cell therapy technologies market today, and over the next 10 years:

Our 305-page report provides 109 tables and 173 charts/graphs exclusively to you.

The report highlights key lucrative areas in the industry so you can target them - NOW.

It contains in-depth analysis of global, regional and national sales and growth.

It highlights for you the key successful trends, changes and revenue projections made by your competitors.

This report tells you TODAY how the cell therapy technologies market will develop in the next 10 years, and in line with the variations in COVID-19 economic recession and bounce. This market is more critical now than at any point over the last 10 years.

Forecasts to 2034 and other analyses reveal commercial prospects

In addition to revenue forecasting to 2034, our new study provides you with recent results, growth rates, and market shares.

You will find original analyses, with business outlooks and developments.

Discover qualitative analyses (including market dynamics, drivers, opportunities, and restraints), Porter's Five Forces Analysis, PEST Analysis and recent developments.

This report includes data analysis and invaluable insight into how COVID-19 will affect the industry and your company. Four COVID-19 recovery patterns and their impact, namely, "V", "L", "W" and "U" are discussed in this report.

Segments Covered in the Report

Product

Sera, Media, Reagent

Cell Engineering Product

Cell Culture Vessels

Equipment

Systems and Software

Others

Cell Type

T-Cells

Stem Cells

Other Cells

Process

Cell Processing

Cell Preservation, Distribution, and Handling

Process Monitoring and Quality Control

End-users

Biopharmaceutical & Biotechnology Companies

CROs, Research Institutes and Cell Banks

In addition to the revenue predictions for the overall world market and segments, you will also find revenue forecasts for five regional and 22 leading national markets:

North America

U.S.

Canada

Europe

Germany

UK

France

Italy

Spain

Rest of Europe

Asia Pacific

Japan

China

India

Australia

South Korea

Rest of Asia Pacific

Latin America

Brazil

Mexico

Rest of Latin America

MEA

GCC

South Africa

Rest of MEA

The report also includes profiles and for some of the leading companies in the Cell Therapy Technologies Market, 2024 to 2034, with a focus on this segment of these companies' operations.

Leading companies profiled in the report

Avantor, Inc.

Bio-Techne Corporation

Bristol-Myers Squibb Company

Corning Incorporated

Danaher Corporation

FUJIFILM Diosynth Biotechnologies

GE Healthcare

Gilead Sciences, Inc.

Lonza

Merck KGaA

Novartis AG

Sartorius AG

Terumo BCT

Thermo Fisher Scientific Inc.

Overall world revenue for Cell Therapy Technologies Market, 2024 to 2034 in terms of value the market will surpass US$7,040 million in 2024, our work calculates. We predict strong revenue growth through to 2034. Our work identifies which organizations hold the greatest potential. Discover their capabilities, progress, and commercial prospects, helping you stay ahead.

How will the Cell Therapy Technologies Market, 2024 to 2034 report help you?

In summary, our 300+ page report provides you with the following knowledge:

Revenue forecasts to 2034 for Cell Therapy Technologies Market 2024 to 2034, with forecasts for product, cell type, process, and end-users, each forecast at a global and regional level - discover the industry's prospects, finding the most lucrative places for investments and revenues.

Revenue forecasts to 2034 for five regional and 22 key national markets - See forecasts for the Cell Therapy Technologies Market, 2024 to 2034 market in North America, Europe, Asia-Pacific, Latin America, and MEA. Also forecasted is the market in the US, Canada, Mexico, Brazil, Germany, France, UK, Italy, China, India, Japan, and Australia among other prominent economies.

Prospects for established firms and those seeking to enter the market - including company profiles for 13 of the major companies involved in the Cell Therapy Technologies Market, 2024 to 2034.

Find quantitative and qualitative analyses with independent predictions. Receive information that only our report contains, staying informed with invaluable business intelligence.

Information found nowhere else

With our new report, you are less likely to fall behind in knowledge or miss out on opportunities. See how our work could benefit your research, analyses, and decisions. Visiongain's study is for everybody needing commercial analyses for the Cell Therapy Technologies Market 2024 to 2034, market-leading companies. You will find data, trends and predictions.

Table of Contents

1 Report Overview

• 1.1 Objectives of the Study
• 1.2 Introduction to Cell Therapy Technologies Market
• 1.3 What This Report Delivers
• 1.4 Why You Should Read This Report
• 1.5 Key Questions Answered by This Analytical Report Include:
• 1.6 Who is This Report For?
• 1.7 Methodology
  • 1.7.1 Market Definitions
  • 1.7.2 Market Evaluation & Forecasting Methodology
  • 1.7.3 Data Validation
    • 1.7.3.1 Primary Research
    • 1.7.3.2 Secondary Research
• 1.8 Frequently Asked Questions (FAQs)
• 1.9 Associated Visiongain Reports
• 1.10 About Visiongain

2 Executive Summary

3 Market Overview

• 3.1 Key Findings
• 3.2 Market Dynamics
  • 3.2.1 Market Driving Factors
    • 3.2.1.1 Advancements in Cellular Biology
    • 3.2.1.2 Increasing Government Investments in Cell-based Research
    • 3.2.1.3 Technological Advancements
    • 3.2.1.4 Increasing GMP Certifications for Cell Therapy Production Facilities
  • 3.2.2 Market Restraining Factors
    • 3.2.2.1 Challenges Associated with Manufacturing Likely to Restrain Industry Growth
    • 3.2.2.2 Low Success Rate
    • 3.2.2.3 Logistical Challenges Projected to Hamper Industry Growth
  • 3.2.3 Market Opportunities
    • 3.2.3.1 Increased Focus on Personalized Medicine
    • 3.2.3.2 Emergence of iPSCs as Alternatives to ESCs
    • 3.2.3.3 Integration of Digital Health Technologies
    • 3.2.3.4 Expanded Therapeutic Applications
• 3.3 COVID-19 Impact Analysis
• 3.4 Porter's Five Forces Analysis
  • 3.4.1 Supplier Power
  • 3.4.2 Buyer Power
  • 3.4.3 Competitive Rivalry
  • 3.4.4 Threat of Substitutes
  • 3.4.5 Threat of New Entrants
• 3.5 PEST Analysis

4 Cell Therapy Technologies Market Analysis by Product

• 4.1 Key Findings
• 4.2 Product Segment: Market Attractiveness Index
• 4.3 Cell Therapy Technologies Market Size Estimation and Forecast by Product
• 4.4 Sera, Media, Reagent
  • 4.4.1 Market Forecast by Region, 2024-2034 (US$ Million, AGR %)
  • 4.4.2 Market Share by Region, 2024 & 2034 (%)
• 4.5 Cell Engineering Product
  • 4.5.1 Market Forecast by Region, 2024-2034 (US$ Million, AGR %)
  • 4.5.2 Market Share by Region, 2024 & 2034 (%)
• 4.6 Cell Culture Vessels
  • 4.6.1 Market Forecast by Region, 2024-2034 (US$ Million, AGR %)
  • 4.6.2 Market Share by Region, 2024 & 2034 (%)
• 4.7 Equipment
  • 4.7.1 Market Forecast by Region, 2024-2034 (US$ Million, AGR %)
  • 4.7.2 Market Share by Region, 2024 & 2034 (%)
• 4.8 Systems and Software
  • 4.8.1 Market Forecast by Region, 2024-2034 (US$ Million, AGR %)
  • 4.8.2 Market Share by Region, 2024 & 2034 (%)
• 4.9 Others
  • 4.9.1 Market Forecast by Region, 2024-2034 (US$ Million, AGR %)
  • 4.9.2 Market Share by Region, 2024 & 2034 (%)

5 Cell Therapy Technologies Market Analysis by Cell Type

• 5.1 Key Findings
• 5.2 Cell Type Segment: Market Attractiveness Index
• 5.3 Cell Therapy Technologies Market Size Estimation and Forecast by Cell Type
• 5.4 T-Cells
  • 5.4.1 Market Forecast by Region, 2024-2034 (US$ Million, AGR %)
  • 5.4.2 Market Share by Region, 2024 & 2034 (%)
• 5.5 Stem Cells
  • 5.5.1 Market Forecast by Region, 2024-2034 (US$ Million, AGR %)
  • 5.5.2 Market Share by Region, 2024 & 2034 (%)
• 5.6 Other Cells
  • 5.6.1 Market Forecast by Region, 2024-2034 (US$ Million, AGR %)
  • 5.6.2 Market Share by Region, 2024 & 2034 (%)

6 Cell Therapy Technologies Market Analysis by Process

• 6.1 Key Findings
• 6.2 Process Segment: Market Attractiveness Index
• 6.3 Cell Therapy Technologies Market Size Estimation and Forecast by Process
• 6.4 Cell Processing
  • 6.4.1 Market Forecast by Region, 2024-2034 (US$ Million, AGR %)
  • 6.4.2 Market Share by Region, 2024 & 2034 (%)
• 6.5 Cell Preservation, Distribution, and Handling
  • 6.5.1 Market Forecast by Region, 2024-2034 (US$ Million, AGR %)
  • 6.5.2 Market Share by Region, 2024 & 2034 (%)
• 6.6 Process Monitoring and Quality Control
  • 6.6.1 Market Forecast by Region, 2024-2034 (US$ Million, AGR %)
  • 6.6.2 Market Share by Region, 2024 & 2034 (%)

7 Cell Therapy Technologies Market Analysis by End-users

• 7.1 Key Findings
• 7.2 End-users Segment: Market Attractiveness Index
• 7.3 Cell Therapy Technologies Market Size Estimation and Forecast by End-users
• 7.4 Biopharmaceutical & Biotechnology Companies
  • 7.4.1 Market Forecast by Region, 2024-2034 (US$ Million, AGR %)
  • 7.4.2 Market Share by Region, 2024 & 2034 (%)
• 7.5 CROs, Research Institutes and Cell Banks
  • 7.5.1 Market Forecast by Region, 2024-2034 (US$ Million, AGR %)
  • 7.5.2 Market Share by Region, 2024 & 2034 (%)

8 Cell Therapy Technologies Market Analysis by Region

• 8.1 Key Findings
• 8.2 Regional Market Size Estimation and Forecast

9 North America Cell Therapy Technologies Market Analysis

• 9.1 Key Findings
• 9.2 North America Cell Therapy Technologies Market Attractiveness Index
• 9.3 North America Cell Therapy Technologies Market by Country, 2024, 2029 & 2034 (US$ Million)
• 9.4 North America Cell Therapy Technologies Market Size Estimation and Forecast by Country
• 9.5 North America Cell Therapy Technologies Market Size Estimation and Forecast by Product
• 9.6 North America Cell Therapy Technologies Market Size Estimation and Forecast by Cell Type
• 9.7 North America Cell Therapy Technologies Market Size Estimation and Forecast by Process
• 9.8 North America Cell Therapy Technologies Market Size Estimation and Forecast by End-users
• 9.9 U.S. Cell Therapy Technologies Market Analysis
• 9.10 Canada Cell Therapy Technologies Market Analysis

10 Europe Cell Therapy Technologies Market Analysis

• 10.1 Key Findings
• 10.2 Europe Cell Therapy Technologies Market Attractiveness Index
• 10.3 Europe Cell Therapy Technologies Market by Country, 2024, 2029 & 2034 (US$ Million)
• 10.4 Europe Cell Therapy Technologies Market Size Estimation and Forecast by Country
• 10.5 Europe Cell Therapy Technologies Market Size Estimation and Forecast by Product
• 10.6 Europe Cell Therapy Technologies Market Size Estimation and Forecast by Cell Type
• 10.7 Europe Cell Therapy Technologies Market Size Estimation and Forecast by Process
• 10.8 Europe Cell Therapy Technologies Market Size Estimation and Forecast by End-users
• 10.9 Germany Cell Therapy Technologies Market Analysis
• 10.10 UK Cell Therapy Technologies Market Analysis
• 10.11 France Cell Therapy Technologies Market Analysis
• 10.12 Italy Cell Therapy Technologies Market Analysis
• 10.13 Spain Cell Therapy Technologies Market Analysis
• 10.14 Russia Cell Therapy Technologies Market Analysis
• 10.15 Rest of Europe Cell Therapy Technologies Market Analysis

11 Asia Pacific Cell Therapy Technologies Market Analysis

• 11.1 Key Findings
• 11.2 Asia Pacific Cell Therapy Technologies Market Attractiveness Index
• 11.3 Asia Pacific Cell Therapy Technologies Market by Country, 2024, 2029 & 2034 (US$ Million)
• 11.4 Asia Pacific Cell Therapy Technologies Market Size Estimation and Forecast by Country
• 11.5 Asia Pacific Cell Therapy Technologies Market Size Estimation and Forecast by Product
• 11.6 Asia Pacific Cell Therapy Technologies Market Size Estimation and Forecast by Cell Type
• 11.7 Asia Pacific Cell Therapy Technologies Market Size Estimation and Forecast by Process
• 11.8 Asia Pacific Cell Therapy Technologies Market Size Estimation and Forecast by End-users
• 11.9 Japan Cell Therapy Technologies Market Analysis
• 11.10 China Cell Therapy Technologies Market Analysis
• 11.11 India Cell Therapy Technologies Market Analysis
• 11.12 Australia Cell Therapy Technologies Market Analysis
• 11.13 South Korea Cell Therapy Technologies Market Analysis
• 11.14 South-East Asia Cell Therapy Technologies Market Analysis
• 11.15 Rest of Asia Pacific Cell Therapy Technologies Market Analysis

12 Latin America Cell Therapy Technologies Market Analysis

• 12.1 Key Findings
• 12.2 Latin America Cell Therapy Technologies Market Attractiveness Index
• 12.3 Latin America Cell Therapy Technologies Market by Country, 2024, 2029 & 2034 (US$ Million)
• 12.4 Latin America Cell Therapy Technologies Market Size Estimation and Forecast by Country
• 12.5 Latin America Cell Therapy Technologies Market Size Estimation and Forecast by Product
• 12.6 Latin America Cell Therapy Technologies Market Size Estimation and Forecast by Cell Type
• 12.7 Latin America Cell Therapy Technologies Market Size Estimation and Forecast by Process
• 12.8 Latin America Cell Therapy Technologies Market Size Estimation and Forecast by End-users
• 12.9 Brazil Cell Therapy Technologies Market Analysis
• 12.10 Mexico Cell Therapy Technologies Market Analysis
• 12.11 Rest of Latin America Cell Therapy Technologies Market Analysis

13 MEA Cell Therapy Technologies Market Analysis

• 13.1 Key Findings
• 13.2 MEA Cell Therapy Technologies Market Attractiveness Index
• 13.3 MEA Cell Therapy Technologies Market by Country, 2024, 2029 & 2034 (US$ Million)
• 13.4 MEA Cell Therapy Technologies Market Size Estimation and Forecast by Country
• 13.5 MEA Cell Therapy Technologies Market Size Estimation and Forecast by Product
• 13.6 MEA Cell Therapy Technologies Market Size Estimation and Forecast by Cell Type
• 13.7 MEA Cell Therapy Technologies Market Size Estimation and Forecast by Process
• 13.8 MEA Cell Therapy Technologies Market Size Estimation and Forecast by End-users
• 13.9 GCC Cell Therapy Technologies Market Analysis
• 13.10 South Africa Cell Therapy Technologies Market Analysis
• 13.11 Rest of MEA Cell Therapy Technologies Market Analysis

14 Company Profiles

• 14.1 Thermo Fisher Scientific Inc.
  • 14.1.1 Company Snapshot
  • 14.1.2 Company Overview
  • 14.1.3 Financial Analysis
    • 14.1.3.1 Net Revenue, 2018-2023
    • 14.1.3.2 Regional Market Shares, 2022
    • 14.1.3.3 R&D, 2018-2023
  • 14.1.4 Product Benchmarking
  • 14.1.5 Strategic Outlook
• 14.2 Novartis AG
  • 14.2.1 Company Snapshot
  • 14.2.2 Company Overview
  • 14.2.3 Financial Analysis
    • 14.2.3.1 Net Revenue, 2018-2023
    • 14.2.3.2 Regional Market Shares, 2022
    • 14.2.3.3 R&D, 2018-2023
  • 14.2.4 Product Benchmarking
  • 14.2.5 Strategic Outlook
• 14.3 Gilead Sciences, Inc.
  • 14.3.1 Company Snapshot
  • 14.3.2 Company Overview
  • 14.3.3 Financial Analysis
    • 14.3.3.1 Net Revenue, 2018-2023
    • 14.3.3.2 R&D, 2018-2023
  • 14.3.4 Product Benchmarking
  • 14.3.5 Strategic Outlook
• 14.4 Merck KGaA
  • 14.4.1 Company Snapshot
  • 14.4.2 Company Overview
  • 14.4.3 Financial Analysis
    • 14.4.3.1 Net Revenue, 2018-2023
    • 14.4.3.2 Regional Market Shares, 2023
    • 14.4.3.3 R&D, 2018-2023
  • 14.4.4 Product Benchmarking
  • 14.4.5 Strategic Outlook
• 14.5 Danaher Corporation
  • 14.5.1 Company Snapshot
  • 14.5.2 Company Overview
  • 14.5.3 Financial Analysis
    • 14.5.3.1 Net Revenue, 2018-2023
    • 14.5.3.2 Regional Market Shares, 2023
    • 14.5.3.3 R&D, 2018-2023
  • 14.5.4 Product Benchmarking
  • 14.5.5 Strategic Outlook
• 14.6 Bristol-Myers Squibb Company
  • 14.6.1 Company Snapshot
  • 14.6.2 Company Overview
  • 14.6.3 Financial Analysis
    • 14.6.3.1 Net Revenue, 2018-2023
    • 14.6.3.2 Regional Market Shares, 2023
    • 14.6.3.3 R&D, 2018-2023
  • 14.6.4 Product Benchmarking
  • 14.6.5 Strategic Outlook
• 14.7 Sartorius AG
  • 14.7.1 Company Snapshot
  • 14.7.2 Company Overview
  • 14.7.3 Financial Analysis
    • 14.7.3.1 Net Revenue, 2018-2023
    • 14.7.3.2 Regional Market Shares, 2023
    • 14.7.3.3 R&D, 2018-2023
  • 14.7.4 Product Benchmarking
  • 14.7.5 Strategic Outlook
• 14.8 FUJIFILM Diosynth Biotechnologies
  • 14.8.1 Company Snapshot
  • 14.8.2 Company Overview
  • 14.8.3 Product Benchmarking
  • 14.8.4 Strategic Outlook
• 14.9 Lonza
  • 14.9.1 Company Snapshot
  • 14.9.2 Company Overview
  • 14.9.3 Financial Analysis
    • 14.9.3.1 Net Revenue, 2018-2023
    • 14.9.3.2 Regional Market Shares, 2023
    • 14.9.3.3 R&D, 2018-2022
  • 14.9.4 Product Benchmarking
  • 14.9.5 Strategic Outlook
• 14.10 GE Healthcare
  • 14.10.1 Company Snapshot
  • 14.10.2 Company Overview
  • 14.10.3 Financial Analysis
    • 14.10.3.1 Net Revenue, 2018-2023
    • 14.10.3.2 Regional Market Shares, 2022
    • 14.10.3.3 R&D, 2018-2023
  • 14.10.4 Product Benchmarking
• 14.11 Terumo BCT
  • 14.11.1 Company Snapshot
  • 14.11.2 Company Overview
  • 14.11.3 Financial Analysis
    • 14.11.3.1 Net Revenue, 2018-2023
    • 14.11.3.2 Regional Market Shares, 2022
  • 14.11.4 Product Benchmarking
  • 14.11.5 Strategic Outlook
• 14.12 Avantor, Inc.
  • 14.12.1 Company Snapshot
  • 14.12.2 Company Overview
  • 14.12.3 Financial Analysis
    • 14.12.3.1 Net Revenue, 2018-2023
    • 14.12.3.2 Regional Market Shares, 2023
  • 14.12.4 Product Benchmarking
  • 14.12.5 Strategic Outlook
• 14.13 Bio-Techne Corporation
  • 14.13.1 Company Snapshot
  • 14.13.2 Company Overview
  • 14.13.3 Financial Analysis
    • 14.13.3.1 Net Revenue, 2018-2023
    • 14.13.3.2 R&D, 2018-2023
  • 14.13.4 Product Benchmarking
  • 14.13.5 Strategic Outlook
• 14.14 Corning Incorporated
  • 14.14.1 Company Snapshot
  • 14.14.2 Company Overview
  • 14.14.3 Financial Analysis
    • 14.14.3.1 Net Revenue, 2018-2023
    • 14.14.3.2 Regional Market Shares, 2023
    • 14.14.3.3 R&D, 2018-2023
  • 14.14.4 Product Benchmarking
  • 14.14.5 Strategic Outlook

15 Conclusion and Recommendations

• 15.1 Concluding Remarks from Visiongain
• 15.2 Recommendations for Market Players